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Abstract
Multivariate data occurs in a wide range of fields, with ever more flexible model specifications
being proposed, often within a multivariate generalised linear mixed effects (MGLME) framework.
In this article, we describe an extended framework, encompassing multiple outcomes of any type,
each of which could be repeatedly measured (longitudinal), with any number of levels, and with any
number of random effects at each level. Many standard distributions are described, as well as non-
standard user-defined non-linear models. The extension focuses on a complex linear predictor for
each outcome model, allowing sharing and linking between outcome models in an extremely flexible
way, either by linking random effects directly, or the expected value of one outcome (or function of
it) within the linear predictor of another. Non-linear and time-dependent effects are also seamlessly
incorporated to the linear predictor through the use of splines or fractional polynomials. We further
propose level-specific random effect distributions and numerical integration techniques to improve
usability, relaxing the normally distributed random effects assumption to allow multivariate t-
distributed random effects. We consider some special cases of the general framework, describing
some new models in the fields of clustered survival data, joint longitudinal-survival models, and
discuss various potential uses of the implementation. User friendly, and easily extendable, software
is provided.
1 Introduction
Given the current trend in improved availability in both access to data, and volume of data, there
is the ever increasing need for flexible, and appropriate statistical modelling techniques, and imple-
mentations. Consider the electronic health record (EHR) setting, in which anonymised patient-level
data can be obtained. In such settings, we inevitably have a complex hierarchical structure to the
data, such as multiple biomarkers measured repeatedly, nested within patients, patients nested within
GP practice area, GP practice area nested within geographical regions, and so on. Further challenges
include time-dependent effects, and non-linear covariate effects, both of which are arguably common-
place in many settings. Therefore, the need for modelling frameworks which can accommodate such
complex structures is paramount.
An area of biostatistics that has received remarkable attention is that of joint modelling. Pre-
dominantly, this has been in the setting of joint longitudinal-survival models (Gould et al., 2015), but
there has also been substantial work in joint modelling of multivariate data, not including survival
outcomes (Goldstein et al., 2009; Macdonald-Wallis et al., 2012; Sayers et al., 2017). In essence, a
model is specified for each outcome, with some form of sharing between outcome models, often done
through shared or correlated random effects. Commonplace in joint longitudinal-survival models is
linking the ‘current value’ of a continuous longitudinal outcome, directly to survival, through its ex-
pected value conditional on subject-specific random effects. Alternatives include transformations of
the current value, for example its gradient or rate of change, or its integral to give a cumulative mea-
sure. Arguably, these are clinically plausible ways to link such outcomes in many settings, and give us
interpretable association parameters, irrespective of how complex the longitudinal model specification
may be (such as when using splines).
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The aim of this article is to develop an extended framework for the analysis of multivariate, mul-
tilevel data, in particular, providing more flexibility in how outcomes can be linked, regardless of the
distribution chosen for each particular outcome, and therefore extending multivariate generalised linear
mixed effects (MGLME) models. Such models are generally estimated by maximising the marginal like-
lihood, integrating out the unobserved random effects at each level of the model (Rabe-Hesketh et al.,
2004). Alternatives include expectation-maximisation approaches, and quasi-likelihood approaches
such as penalised quasi-likelihood (PQL) (Tuerlinckx et al., 2006; Rasbash et al., 2009). In this arti-
cle we concentrate on the Newton-Raphson approach to maximising the marginal likelihood.
A crucial challenge in the estimation of MGLME models is integrating out the random effects at
each level. A number of integration techniques have been proposed, and extensively studied, includ-
ing both non-adaptive and fully adaptive Gauss-Hermite quadrature, Monte Carlo integration, and
importance sampling (Tuerlinckx et al., 2006; Pinheiro and Bates, 1995; Rabe-Hesketh et al., 2002).
The default choice of the core software packages for fitting MGLME models, such as nlme in R, PROC
NLMIXED in SAS, and gsem in Stata, is adaptive Gauss-Hermite quadrature (AGHQ). A criticism of
AGHQ is that it’s computational burden grows exponentially as the dimension of the random effects,
at a particular level, grows. This generally makes it infeasible for use in the high dimensional random
effects setting. An alternative which has been proposed for such a setting is Monte Carlo integration
(MCI), which involves making random draws from the random effects distribution (with mean and
variance elements at their current estimates). This is appealing as the number of draws doesn’t nec-
essarily have to increase with the addition of more random effects. Indeed the appeal of MCI is in its
simplicity, and MCI has been employed in a wide variety of areas (McCulloch, 1997; Lin et al., 2002).
All one needs to do is randomly sample from a distribution, and it can be specified as your random
effect distribution. This allows a convenient and easily implementable way to assume, for example,
multivariate t-distributed random effects. This can be considered a sensitivity analysis for all models
used within this framework. We consider this extension in this paper, in particular using quasi-Monte
Carlo methods to reduce the number of samples required (Drukker et al., 2006).
Furthermore, consider a three level model, where often we may only have one random effect at
the highest level, many at level 2, and therefore may wish to consider level-specific random effect
distributions, which allow a sensitivity analysis to be conducted at each level. This then motivates
level-specific integration techniques, such as using the gold standard AGHQ at level 1 if we have a
normally distributed random effect, and MCI at level 2 if we have multivariate t-distributed random
effects, to provide a more usable implementation. We also consider these extensions in this paper.
The paper is organised as follows. In Section 2, we describe the general likelihood, and describe
numerical integration techniques for evaluating the likelihood, proposing level-specific random effect
distributions and integration techniques. We then introduce our extended complex linear predictor,
and an extensive range of possible distributional models for an outcome. The range includes the
standard distributions, but also more general distributions, such as non-linear specifications, and
general survival models, allowing for delayed entry and censoring. In Section 3 we describe some special
cases of the framework, each of which can be considered a new development in the literature, including
general level flexible parametric survival models, relative survival models, joint frailty models, joint
longitudinal-survival models, non-linear mixed effect models, and general hazard models. Throughout
the article, we will illustrate the accompanying software package, through example syntax, to illustrate
how easy it is to apply the models described in this article, and indeed extend them. Finally, in Section
4 we conclude with a discussion, including some directions for future research.
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2 Multivariate generalised linear and non-linear mixed effects mod-
els
2.1 Likelihood
We begin with a single level model with i = 1, . . . , n response variables, and therefore can write the
conditional joint density function for a given observation as
p(y|x, b,β) =
n∏
i=1
pi(yi|x, b,β)
where x is a vector of explanatory variables, b is a vector of random effects, and β is our overall
parameter vector. Extending this to a two-level model follows, we have the cluster-specific contribution
to the likelihood,
p(y|x, b,β) =
n∏
i=1
ti∏
j=1
pi(yij |x, b,β) (1)
where ti is the number of observations within the ith cluster. The log likelihood is obtained by
integrating out the unobserved random effects, to obtain a marginal log likelihood,
ll(β) = log
∫
Rr
p(y|x, b,β)φ(b|Σb) db (2)
where Rr is the r-dimensional space, with each dimension spanning the real number line, and r
the dimension of the random effects b. We assume φ() is multivariate normal density for b, with
mean vector 0 and variance-covariance matrix Σb. Equation (1) can be expanded with further levels
of nesting, with Σb becoming block diagonal, with a block for each level. Alternatively, following
Rabe-Hesketh et al. (2005), exploiting conditional independence among level (l − 1) units given the
random effects Bl, where Bl = (bl, . . . , bL), we can write a general level model, with the log likelihood
for a unit at the highest level L, as,
llLi = log
∫
φ(b(L)|Σ(L))
∏
p(L−1)(y|x, bL,β) db(L)
= log
∫
φ(b(L)|Σ(L)) exp
[∑
log p(L−1)(y|x, bL,β)
]
db(L) (3)
where, for l = 2, . . . , L
p(l)(y|x,Bl+1,β) =
∫
φ(b(l)|Σ(l))
∏
p(l−1)(y|x,Bl,β) db(l)
=
∫
φ(b(l)|Σ(l)) exp
(∑
log p(l−1)(y|x,Bl,β)
)
db(l) (4)
We will refer to this second log likelihood formulation as a nested log likelihood in the remainder of the
article. In order to calculate our marginal log likelihood, we must numerically integrate the random
effects at each level.
2.2 Estimation
Throughout this article, we use direct maximisation of the marginal log-likelihood utilising the Newton-
Raphson algorithm, with score and Hessian elements calculated using finite differences (Gould et al.,
2010). The challenge in evaluating a general likelihood such as that in Equation (2) lies in integrating
out the random effects at each level. Widely considered the numerical integration technique of choice,
we apply mean-variance fully adaptive Gauss-Hermite quadrature as our default integration technique.
Applying AGHQ to Equations (3) and (4), we have,
llLi ≈ log

 Q∑
qrL=1
wqrL · · ·
Q∑
q1=1
wq1 exp
(∑
log p(L−1)(y|x, aq1 , . . . , aqrL ,B(L))
) (5)
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and
p(l)(β|B(l+1)) ≈
Q∑
qr
l
=1
wqr
l
· · ·
Q∑
q1=1
wq1 exp
(∑
log p(l−1)(y|x, aq1 , . . . , aqrl ,B(l))
)
(6)
where aq and wq are appropriate nodes and weights, respectively, with Q the number of quadrature
points per dimension. The adaptive nature of the approximation greatly improves accuracy compared
to its non-adaptive version, meaning a greatly reduced number of quadrature nodes can be used per di-
mension. We advise using an increasing number of AGHQ points to ensure an accurate approximation
is obtained.
A criticism of AGHQ is that it doesn’t scale well in the presence of many random effects, predom-
inantly with respect to its computational burden growing exponentially with every additional random
effect. For example, if we conduct 7-point quadrature, with 2 random effects, we evaluate our likeli-
hood at 72 = 49 locations. If we had 6 random effects, this would result in 76 = 117, 649 evaluations.
This has motivated alternative techniques.
2.2.1 Monte Carlo integration
An alternative to AGHQ is that of Monte Carlo (MC) integration (Tuerlinckx et al., 2006). Consider
a likelihood function of a two level model, where we need to integrate out the random effects.
ll(β) = log
∫
Rr
p(y|x, b,β)φ(b|Σb) db
A finite sample approximation to this integral is obtained by samplingM random draws fromN(0,Σb),
and computing the sample mean
ll(β) ≈ 1
M
M∑
m=1
p(y|x, bm,β)
The important thing to note is M doesn’t have to increase when extra random effects are added. This
makes MC integration attractive in the presence of high dimensional random effects, in comparison
to quadrature. However, M must be sufficiently large to ensure an accurate approximation. Vari-
ance reduction techniques can be employed to reduce the required M , such as antithetic sampling
(Hammersley and Morton, 1956), but in this article we make use of Halton sequences (Drukker et al.,
2006), which are based on primes, and have been shown to greatly reduce the number of draws required.
Similarly to Gauss-Hermite quadrature, MC integration can be improved by an adaptive procedure
just like AGHQ, resulting in an importance sampling approximation Tuerlinckx et al. (2006).
Since MC integration simply relies on being able to sample from our proposed random effects
distribution, φ(b), there is no restriction on the distribution that we choose (though we assume it has
mean zero on the scale of the linear predictor). Therefore, we can relax the normality assumption
placed on the random effects, by using for example a multivariate t-distribution, and simply sampling
from that instead (Hofert, 2013). Once more this opens up a broader range of models, or indeed a
sensitivity analysis to a model assuming normally distributed random effects (Lange et al., 1989).
2.2.2 Level-specific integration techniques and random effect distributions
The methods described above all assume the same distributional family for the random effects, across
all levels of a model. In this section we discuss how to relax this assumption. Consider,
llLi = log
∫
φL(b
(L)|Σ(L))
∏
p(L−1)(y|x, bL,β) db(L)
= log
∫
φL(b
(L)|Σ(L)) exp
[∑
log p(L−1)(y|x, bL,β)
]
db(L) (7)
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where, for l = 2, . . . , L
p(l)(y|x,Bl+1,β) =
∫
φl(b
(l)|Σ(l)
∏
p(l−1)(y|x,Bl,β) db(l)
=
∫
φl(b
(l)|Σ(l)) exp
(∑
log p(l−1)(y|x,Bl,β)
)
db(l) (8)
where φl(b
(l)|Σ(l)) for l = 2, . . . , L, now represents the distribution of the random effects at the lth
level. This formulation now allows us to specify different distributions at each level. For example,
let’s consider a three-level model, with a random intercept at the highest level, and 4 random effects
at level 2. Our standard approach would be to assume normally distributed random effects at levels 2
and 3, but we can now investigate the robustness to this assumption, not only by using t-distributed
random effects for all levels, but investigating level specific sensitivity to the assumption, by first
assuming t-distributed random effect at level 3 and normal distributed random effects at level 2, and
vice versa. This provides both an effective method of sensitivity analysis, but also a more robust
multilevel analysis.
Assuming different random effects distributions at different levels raises the issue of which integra-
tion techniques can be applied effectively. It is arguably only sensible to use Monte Carlo integration
when L=2, as the computational burden increases dramatically. Therefore, when using level spe-
cific distributions, we propose using level specific integration techniques. Consider the example of a
three-level model, where often we would only have a random intercept at the highest level, with many
random effects at level 2. In this situation, we suggest using AGHQ at the highest level, but employ
MCI at level 2 so as to accommodate the possibly many random effects at that level.
2.3 Linear predictors
The standard linear predictor for a general level model can be written as follows,
η =Xβ +
L∑
l=2
X lbl (9)
where subscripts are omitted for ease of exposition. We have X our vector of covariates, which could
vary at any level, with associated fixed effect coefficient vector β, andX l the vector of covariates with
random effects bl at level l.
In an attempt to maintain substantial generality in model specification, we extend the linear
predictor shown in Equation (9) to a highly flexible specification, which forms the basis for the extended
framework. It consists of components, indexed by r, and each rth component consists of elements,
indexed by s. These of course can vary between parameters. For simplicity, in the exposition below, we
assume each response variable has one parameter with a complex linear predictor, with the remaining
parameters assumed scalar. We relax this restriction in Section 3.6. Therefore, for the ith response
variable, we define the linear predictor ηi as,
ηi = gi(E[yi|X, b]) =
Ri∑
r=1
Sir∏
s=1
ψirs (10)
where gi() is the link function for the ith response, µi = E[yi|X, b] = g−1(ηi) is the expected value for
the ith response variable yi. We suppress dependence on covariates and random effects in the notation,
for ease of exposition. We have ψirs, which is the sth functional element, for the rth component, for
the ith response, with r = 1, . . . , Ri and s = 1, . . . , Sir. Some particular cases that ψirs can take are,
ψirs = Xirs(t) (11)
where Xirs is a possibly time-dependent covariate, or indeed could be a simple vector of 1’s,
ψirs = β (12)
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where β is a parameter to be estimated,
ψirs = b (13)
where b is a latent variable, with level and unit indexes omitted for simplicity, commonly assumed to
be normally distributed. All random effects at a particular level are stacked and assumed multivariate
normal, by default. We further have,
ψirs = q(t) (14)
where q(t) is some function of time t, such as a linear function, or something more complex such as
fractional polynomials or splines, to allow modelling of time-dependent effects,
ψirs = drs(E[yj |X, b]), where j = 1, . . . , k, j 6= i (15)
where drs() is a general function, which could be equivalent to the appropriate link function gj() or
its inverse g−1j (), or something more complex, such as the first or second derivative with respect to
t, or the integral of the expected value up to time t, when a response is modelled as a function of
time. Examples of these include the joint longitudinal-survival framework (Gould et al., 2015). Such
a general structure allows the expected value of one outcome to be dependent on the expected value
of another, with even further levels of nesting if so desired.
The combination of the elements to form components can form highly flexible model specifications
for use in numerous settings. Some examples will be shown in Section 3.
2.4 Distributional choice
In this section we discuss distributional models for pi(yi|x, b,β). A variety of standard distributional
choices can be used in combination with the complex linear predictor described in the previous section.
We consider the Gaussian distribution, where,
pi(yi|x, b,β) = 1√
2πσ
exp
(
(yi − µi)2
2σ2
)
which assumes an identity link function. We have the Poisson distribution,
log pi(yi|x, b,β) = −µ+ yi log µi − log Γ(i+1)
which assumes a log link function. We have the Bernoulli distribution,
log pi(yi|x, b,β) = yi log(µi) + (1− yi) log(1− µi)
where in this case µ is the probability of success. The default link function is the logit. We have the
beta distribution, which is a fractional response model, where the outcome Y is assumed to take a
value between 0 and 1.
log pi(yi|x, b,β) = logΓ(s)− log Γ(µis)− log Γ(s− µs)
+ (µis− 1) log(yi) + (s− µis− 1) log(1− yi)
where µi is the mean of Y and s is a scale parameter fitted on the log scale. The default link function
is the logit. We have the binomial distribution, which generalises the Bernoulli distribution as the
sum of k independent Bernoulli outcomes. The response Y is assumed to take the values 0, 1, . . . , k,
log pi(yi|x, b,β) = logΓ(k + 1)− log Γ(yi + 1)− log Γ(k − yi + 1)
+ y log µi + (1− yi) log(1− µi)
where µ is the expected value for a single Bernoulli outcome. The default link function is the logit.
We have the negative binomial distribution, where
log pi(yi|x, b,β) = logΓ(yi +m)− log Γ(yi + 1)− log Γ(yi)
+m log pi + yi log(1− pi)
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where under mean dispersion we have,
m = 1/α
pi =
1
1 + αµi
where µi is the expected value of Y and α is a scale parameter, fitted on the log scale. All the
distributions described above are inbuilt to the associated software.
2.4.1 Non-linear models
Clearly the above is by no means an exhaustive list; however, we can provide such functionality to
allow essentially any function to be specified, to take on that of pi(yi|x, b,β), and still sync with the
general level likelihood, and complex linear predictor from Equation (10). In other words, non-linear
mixed effects models, such as those used in pharmaco-kinetic or growth modelling studies, are also
applicable within this framework (Drikvandi, 2017). We show an example of this in Section 3.6.
2.4.2 Survival models
Moving to time-to-event distributions, we have the log likelihood for a survival outcome,
ll(yi|x, b,β) = di log p(yi) + (1− di) log S(yi) (16)
where p() is the density function for Y , S() is the survival function, di is the event indicator (0
censored, 1 event), and yi is the observed survival/censoring time. Here we describe some of the
standard parametric survival models used widely in practice. For an exponential distribution, we have
S(y) = exp(−λyi)
λ = exp(ηi)
For the Weibull distribution, we have
S(y) = exp(−λyγi )
λ = exp(ηi)
For the Gompertz distribution, we have
S(y) = exp(−λγ−1(eγyi − 1))
λ = exp(ηi)
For the log normal distribution, we have
S(y) = 1− Φ
(
log(yi)− ηi
σ
)
For the log-logistic distribution, we have
S(y) = (1 + (λyi)
1/γ)−1
In terms of time-to-event data, we can also provide close to an exhaustive list, by allowing the analyst
to specify a function of the (log) hazard function, which is all that is required, since the cumulative
hazard function can be estimated using numerical quadrature (Crowther and Lambert, 2014). The
log likelihood in Equation (16) can be written only in terms of the hazard function
ll(yi|x, b,β) = di log h(yi)−
∫ yi
0
h(u) du
7
We can then apply numerical integration, to obtain
ll(yi|x, b,β) = di log h(yi)− yi
2
Q∑
q=1
wqh(
yi
2
uq +
yi
2
) (17)
where u andw are sets of appropriate nodes and weights. Equation (17) implies that given any function
for the (log) hazard, we can estimate a model, syncing with the complex linear predictor. Further
details of this general hazard approach can be found in Crowther and Lambert (2014). Alternatively, if
both the (log) hazard function and cumulative hazard function can be written as closed form functions,
then this again will sync with the general likelihood and complex linear predictor described above. For
completeness, the cumulative hazard function may be specified, with the hazard function estimated
using numerical differentiation. We show an example of this in Section 3.7.
3 Some particular cases
In this section we describe some special cases of the general framework, each of which can be considered
a new proposal. We illustrate them through example syntax, using the associated Stata package
developed with this article, namely, the megenreg command.
3.1 A general level parametric survival model
Crowther et al. (2014) developed the extension of the Royston-Parmar flexible parametric survival
model to a two-level mixed effect model (Crowther et al., 2014). At the highest level, they allowed
any number of normally distributed random effects, and illustrated the approach in the analysis of
recurrent event data with events nested within patients incorporating a random intercept, and the
individual patient data meta-analysis of survival data with patients nested within trials incorporating
a random treatment effect. In this article, we can easily generalise to any number of levels, and of
course any number of random effects at each level. The Royston-Parmar model uses restricted cubic
splines of log time, on the log cumulative hazard scale, with log likelihood defined as,
ll(y) = d
{
s(log(y)|βk) + η + ∂s(log(y)|βk) + η
∂y
}
− exp [s(log(y)|βk) + η]
Further details can be found in the book on Royston-Parmar models by Royston and Lambert (2011).
We first revisit one of the datasets analysed in Crowther et al. (2014) which consists of 38 patients with
kidney disease (McGilchrist and Aisbett, 1991). The outcome of interest is infection at the catheter
insertion point, with our baseline being time of initial catheter insertion. Patients can experience up
to two recurrences of infection, resulting in a total of 58 events. The data set-up is as follows,
. list patient time infect age female in 1/4, noobs
patient time infect age female
1 8 1 28 0
1 16 1 28 0
2 13 0 48 1
2 23 1 48 1
where patient contains the unique identifier for patients, time is the time of infection, infect is
the event (1) or censoring (0) indicator, age contains the patient’s age at baseline, and female an
indicator variable with 0 being male and 1 being female. We can fit the same final model, which used
3 degrees of freedom to model the baseline, adjusting for age and gender, and a normally distributed
frailty term, using megenreg, as follows,
. megenreg (time age female M1[patient], family(rp, failure(infect) scale(h) df(3)))
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We first write the command name, followed by a model specification within brackets (). The first
variable time defines the response variable, followed by elements of the complex linear predictor. Ele-
ments, as defined above, are separated by spaces. Random effects are defined by starting with a capital
letter, with the cluster indicator variables specified within square brackets []. The cluster hierarchy is
expressed in a simple way by using < or > (when there are more than 2 levels, examples below). The
example shows patient at the highest level, and observations nested within. Model specific options
follow the comma, defining the distribution with family(). As it’s a survival distribution, we also
specify the failure() option, defining which variable contains the event indicator, infect in this case.
Other model specific options, such as df(), are available. In this case, we specify a Royston-Parmar
survival model with rp, and use three degree of freedom (spline terms), through df(3), and specify
scale(h) to model on the log cumulative hazard scale. Results are presented in Table 1. We can now
conduct a sensitivity analysis, relaxing the normality assumption on the frailty term, by assuming a
t-distributed frailty. In this case we assume 3 degrees of freedom for the t-distribution, as follows,
. megenreg (time age female M1[patient], family(rp, failure(infect) scale(h) df(3)))
> , redistribution(t) df(3)
We use the redistribution(t) option to specify t-distributed random effects, and df() to specify
the degrees of the freedom for the t-distribution. Results are also presented in Table 1, from which
we can see the estimated conditional log hazard ratios for age and gender are fairly robust to the
normality assumption of the frailty term.
Table 1: Results from a Royston-Parmar frailty model with either normal or t-distributed random
intercept.
Parameter
Normal t
Estimate 95% CI Estimate 95% CI
age 0.007 0.018 0.032 0.007 0.015 0.029
female 1.465 2.428 -0.502 1.658 2.620 -0.697
1 rcs1 1.753 1.281 2.225 1.741 1.285 2.196
1 rcs2 0.355 0.025 0.684 0.373 0.040 0.706
1 rcs3 0.222 0.409 -0.036 0.225 0.409 -0.041
cons 0.348 1.663 0.967 0.136 1.341 1.069
Now consider a three-level example, required when meta-analysing individual patient recurrent
event data, with events nested within patients nested within trials. We illustrate how to fit such a
model using megenreg, investigating the effect of a binary treatment group, trt, as follows,
. megenreg (time trt M1[trial] M2[trial>patient], family(rp, failure(died) scale(h) df(3)))
where we now have a random effect M1[trial] at the trial level, and a random effect at the patient
level, M2[trial>patient]. Rondeau et al. (2006) developed a three-level gamma frailty model, with
cubic M-splines for the hazard function. Numerical integration was required to integrate out the
random effects at each of the levels. Our implementation goes beyond this, to allow any number of
normally distributed random effects at each level, such as a random treatment effect which would
often be required in the meta-analysis context at the trial level. This can be fitted as follows,
. megenreg (time trt M1[trial] trt#M1[trial] M2[trial>patient], family(rp, failure(died) scale(h) df(3)))
Here, components of the same element are separated by a #. This therefore defines a random
intercept and random treatment effect at the trial level, level 3, and a random intercept at the patient
level, level 2. By default, an independent variance-covariance structure for the random effects at each
level is assumed.
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The extension to time-dependent effects can be done through an additional component, for exam-
ple, we can specify a time-dependent treatment effect by forming an interaction between our treatment
variable trt and a function of time, say log(t), as follows,
. megenreg (stime trt trt#fp(0)@phi M1[id1] M2[id1>id2], family(rp, failure(died) scale(h) df(3))
> timevar(stime))
We use the convenience function fp() to denote a fractional polynomial, in this case of degree 1
with power 0, i.e. log time, and estimate a coefficient (potentially a vector if degree > 1) for it called
phi using the @ notation. We then must tell megenreg our variable which represents time through
timevar(). If a function of time is included in the linear predictor of a log time or log hazard scale
survival outcome model, then it is automatically detected by the program and the required numerical
integration will be applied to calculate the cumulative hazard function, necessary for the likelihood.
In the Royston-Parmar model, we are already on the (log) cumulative hazard scale, and therefore
numerical differentiation will be applied in this case. An essential capability is to also allow non-linear
covariate effects, for example we can add age and age squared very simply.
. gen age2 = age^2
. megenreg (stime trt trt#fp(0)@phi age age2 M1[id1] M2[id1>id2], family(rp, failure(died) scale(h) df(3))
> timevar(stime))
Similarly, splines can also be included as standard variables. The examples shown above provide
an extremely flexible, and extendable framework in which to model clustered survival data, capturing
often seen complexities such as time-dependent effects and non-linear covariate effects.
3.2 A general level parametric relative survival model
Relative survival models are used widely, particularly in population based cancer epidemiology (Dickman et al.,
2004). Generally they are concerned with modelling the excess mortality in a population with a
particular disease, compared to a reference population, which usually comprises national life table
information. One of the benefits of the approach is that they do not rely on accurate cause of death
information. Concentrating again on the Royston-Parmar model, the log likelihood for a relative
survival model can be written as follows,
ll(y) = d log
{
exp [s(log(y)|βk) + η]× ∂s(log(y)|βk) + η
∂y
+ h∗(y)
}
− exp [s(log(y)|βk) + η]
where h∗(y) is the expected mortality in the reference population, at the observations time y. Usually
this is matched based on age, sex, and calendar year of diagnosis. The two-level relative survival
Royston-Parmar model was developed by Crowther (2017), and can be extended to a general level
model here. Such a setting may occur when we have observations nested within hospital districts,
nested within geographical areas such as counties. The following fits a three-level relative survival
model, assuming the Royston-Parmar model with three degrees of freedom to model the baseline,
allowing for a time-dependent treatment effect and non-linear function of age.
. megenreg (stime trt trt#fp(0)@phi M1[id1] M2[id1>id2], family(rp, failure(died) df(3) scale(h)
> bhazard(bhaz)) timevar(stime))
Where the bhazard() option defines the variable which contains the expected mortality at a
patient’s survival time, in the reference population (often matched on year of diagnosis, sex and age).
The above extends relative survival models to any number of levels, random effects, etc..
3.3 General level joint frailty survival models
An area of intense research in recent years is in the field of joint frailty survival models, for the
analysis of joint recurrent event and terminal event data. Here we focus on the two most popular
approaches, proposed by Liu et al. (2004) and Mazroui et al. (2012). In both, we have a survival
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model for the recurrent event process, and a survival model for the terminal event process, linked
through shared random effects. In the first specification, we have one random effect which accounts
for the correlation between recurrent events, and which is then included in the linear predictor for
the terminal event model, multiplied by an association parameter, which estimates the strength of the
relationship between the two processes. For example,
hij(y) = h0(y) exp(X1ijβ1 + bi)
λi(y) = λ0(y) exp(X1iβ2 + αbi)
(18)
where hij(y) is the hazard function for the jth event of the ith patient, λi(y) is the hazard function
for the terminal event, and bi ∼ N(0, σ2). We can fit such a model with megenreg, adjusting for
treatment in each outcome model,
. megenreg (rectime trt M1[id1] , family(rp, failure(recevent) scale(h) df(5)))
> (stime trt M1[id1]@alpha , family(rp, failure(died) scale(h) df(3)))
We now have two model specifications, each of which can be completely different. We define a
random effect with the same name in each linear predictor, which means only one random effect has
been defined, but it is included in both outcome models. By default a random effect has a coefficient
of one, but by adding the @alpha at the end of the element, means a parameter (called alpha in the
results table, as it uses the name the user provides) will be estimated instead. This provides a highly
convenient way of linking random effects between outcome models.
The second approach consists of two random effects included in the recurrent event model, one of
which is also included in the linear predictor of the terminal event model, as follows,
hij(y) = h0(y) exp(X1ijβ1 + b1i + b2i)
λi(y) = λ0(y) exp(X1iβ2 + b2i)
(19)
where b1i ∼ N(0, σ21) and b2i ∼ N(0, σ22). We give an example of how to fit this model with megenreg,
this time illustrating how to use different distributions for the recurrent event and terminal event
processes,
. megenreg (rectime trt M1[id1] M2[id1] , family(weibull, failure(recevent)))
> (stime trt M2[id1] , family(rp, failure(died) scale(h) df(3)))
This defines two random effects at the id1 level, which by default have an independent covariance
structure. All of the extensions discussed in Section 3.1, i.e. higher levels, time-dependent effects,
non-linear covariate effects and the relative survival extension can be included just as before. The
examples above extend the Royston-Parmar model to the joint frailty setting.
3.4 Generalised multivariate joint longitudinal-survival models
Joint longitudinal-survival models have been widely developed, but there are many avenues of re-
search where they are lacking in terms of methodological development, and importantly, accessible
implementations (Gould et al., 2015).
3.4.1 Multiple longitudinal outcomes
A current topic is the ability to model multiple longitudinal outcomes, and link each to survival
(Hickey et al., 2016). For simplicity, we describe a situation of two continuous biomarkers (i = 2, 3),
where we wish to investigate the association between each value of the biomarker and the risk of event
(i = 1), commonly known as the current value association structure. We model the survival outcome
using a Weibull model. Due to the flexibility of the complex linear predictor, we can further extend
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this framework, by investigating whether there is an interaction between the two biomarkers, and the
risk of event. We make no restriction that the two biomarkers must be measured at the same time,
only the commonly made assumption that each time schedule is non-informative. Our model is as
follows,
Y1 ∼Weib(λ, γ)
Y2 ∼ N(µ2, σ22)
Y3 ∼ N(µ3, σ23)
The linear predictor of the survival outcome can be written as follows,
η1(t) =Xβ0 + E[y2(t)|η2(t)]β1 + E[y3(t)|η3(t)]β2 + E[y2(t)|η2(t)]× E[y3(t)|η3(t)]β3
where X is a vector of baseline covariates, with associated log hazard ratios, β0. We apply this
model to a commonly used joint model example dataset in the area of primary biliary cirrhosis. Our
survival outcome is time to death from any cause, and we have available two biomarkers, namely,
serum bilirubin and prothrombin index, both markers of liver function. We illustrate the data setup
required, showing the data for a particular patient,
. list id logb logp time trt stime died if id==3, noobs
id logb logp time trt stime died
3 .3364722 2.484907 0 D-penicil 2.77078 1
3 .0953102 2.484907 .481875 D-penicil . .
3 .4054651 2.484907 .996605 D-penicil . .
3 .5877866 2.587764 2.03428 D-penicil . .
where logb and logp are the log of serum bilirubin and log(prothrombin index) ×10, respectively,
time is the time at which the biomarkers were measured, trt is treatment group (either placebo or
D-penicillamine), stime is the observed event time, and died is the event indicator. We can then
apply our joint model using,
. megenreg (stime trt EV[logb]@beta1 EV[logp]@beta2 EV[logb]#EV[logp]@beta3
> , family(weibull, failure(died)))
> (logb fp(1)@l1 fp(1)#M2[id] M1[id] , family(gaussian) timevar(time))
> (logp fp(1)@l2 fp(1)#M4[id] M3[id] , family(gaussian) timevar(time))
> , covariance(unstructured)
where we assume a random intercept and random linear trend for each of the biomarkers. We specify
an unstructured variance-covariance structure through the covariance() option. Since we want to
link the current value of the biomarkers to survival, we use the EV[] syntax to link the expected value
of an outcome within the linear predictor of another. They are referred to by using the appropriate
response variable name within the square brackets. Since we are linking a time-dependent expected
value to survival, we must explicitly use the fp() or rcs() (for restricted cubic splines) functions when
using time, as it must be numerically integrated out in the survival outcome model. For each Gaussian
response, we must specify the variable which holds the time of measurements, which does not have to
be the same between outcomes, as in this case. Further inbuilt functions include the first and second
derivatives of the expected value, with respect to time, using dEV[] and d2EV[], respectively, and the
integral of the expected value, using iEV[]. Results from fitting the above model are presented in
Table 2.
We can conduct a sensitivity analysis for the above model by using multivariate t-distributed
random effects, as follows,
. megenreg (stime trt EV[logb]@beta1 EV[logp]@beta2 EV[logb]#EV[logp]@beta3
> , family(weibull, failure(died))
> (logb fp(1)@l1 fp(1)#M2[id] M1[id] , family(gaussian) timevar(time))
> (logp fp(1)@l2 fp(1)#M4[id] M3[id] , family(gaussian) timevar(time))
> , covariance(unstructured) redistribution(t) df(3)
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Table 2: Results of multivariate joint model with either normal of t distributed random effects.
Parameter Normal t
Survival HR 95% CI HR 95% CI
a1 2.908 2.394 3.531 2.864 2.379 3.448
a2 1.710 1.418 2.062 1.615 1.394 1.872
trt 1.094 0.762 1.569 1.012 0.711 1.439
lambda 0.000 0.000 0.000 0.000 0.000 0.000
gamma 0.969 0.812 1.156 0.980 0.826 1.162
Longitudinal 1 Estimate 95% CI Estimate 95% CI
cons1 0.491 0.377 0.605 0.280 0.211 0.349
l1 0.195 0.167 0.223 0.100 0.085 0.114
sd(resid1) 0.346 0.333 0.359 0.349 0.336 0.362
Longitudinal 2 Estimate 95% CI Estimate 95% CI
cons2 23.575 23.479 23.671 23.492 23.415 23.568
l2 0.226 0.192 0.260 0.159 0.139 0.179
sd(resid2) 0.746 0.718 0.775 0.759 0.732 0.786
Random effects Estimate 95% CI Estimate 95% CI
sd(cons1) 1.001 0.921 1.088 0.758 0.711 0.807
sd(cons2) 0.195 0.170 0.224 0.186 0.176 0.197
sd(l1) 0.721 0.640 0.811 0.469 0.418 0.526
sd(l2) 0.185 0.154 0.224 0.156 0.137 0.178
corr(cons1,l1) 0.455 0.312 0.578 0.236 0.139 0.330
corr(cons1,cons2) 0.596 0.487 0.687 0.720 0.629 0.791
corr(cons1,l2) 0.508 0.346 0.641 0.111 -0.056 0.271
corr(l1,cons2) 0.437 0.251 0.592 0.105 -0.010 0.216
corr(l1,l2) 0.524 0.332 0.675 0.754 0.678 0.814
corr(cons2,l2) 0.161 -0.074 0.378 0.022 -0.150 0.192
where we specify the redistribution(t) and choose a degrees of freedom with df(). Results of this
model are also shown in Table 2, indicating some impact on estimates for the longitudinal model for
log serum bilirubin (biomarker 1). This provides evidence that the more robust model may be needed.
A further extension, which is simple to incorporate, is to allow time-dependent association param-
eters, i.e. non-proportional hazards in the association parameter. We can investigate the presence of
non-proportional hazards in the association between the second biomarker, and survival, by forming
an interaction between the expected value for that outcome, and a function of time, as follows,
η1(t) =Xβ0 + E[y2(t)|η2(t)]β1 +E[y3(t)|η3(t)]β2(t)
=Xβ0 + E[y2(t)|η2(t)]β1 +E[y3(t)|η3(t)]× β2 + E[y3(t)|η3(t)]× β3 × t
This model is implemented using megenreg as follows,
. megenreg (stime trt EV[logb]@beta1 EV[logp]@beta2 fp(0)#EV[logp]@beta3
> , family(rp, failure(died) df(3)) timevar(stime))
> (logb fp(1)@l1 fp(1)#M2[id] M1[id] , family(gaussian) timevar(time))
> (logp fp(1)@l2 fp(1)#M4[id] M3[id] , family(gaussian) timevar(time))
> , covariance(unstructured)
where beta2 gives the log hazard ratio for a one unit increase in the biomarker at baseline, t = 0, and
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beta3 is the linear change in beta2 over log time. The function of time can be as simple or complex
as required, for example to allow non-linearity.
3.4.2 Competing risks
Extending to a cause-specific competing risks model can also be done in an extremely simple way.
Consider the hypothetical situation where we have cause of death information for the PBC example
above. We assume patient’s either died from PBC or from another cause. We now consider this
data structure, where we have stime which is a patient’s time of death or censoring, but now have
cause-specific event indicators, called diedpbc and diedother
. list id logb logp time trt stime diedpbc diedother if id==3, noobs
id logb logp time trt stime diedpbc diedother
3 .3364722 2.484907 0 D-penicil 2.77078 1 0
3 .0953102 2.484907 .481875 D-penicil . . .
3 .4054651 2.484907 .996605 D-penicil . . .
3 .5877866 2.587764 2.03428 D-penicil . . .
where diedpbc indicates whether a patient died from PBC (1) or was censored at their stime (0),
and diedother indicates whether a patient died from another cause (1) or was censored (0). We can
now fit cause-specific models extremely easily as follows,
. megenreg
> (stime trt EV[logb]@a1 EV[logp]@a2 , family(weibull, failure(diedpbc)))
> (stime trt EV[logb]@a3 EV[logp]@a4 , family(gompertz, failure(diedother)))
> (logb fp(1 2)@l1 fp(1)#M2[id] M1[id] , family(gaussian) timevar(time))
> (logp rcs(df(3))@l2 fp(1)#M4[id] M3[id] , family(gaussian) timevar(time))
Parameters a1 and a2 gives us the cause-specific association between the current values of serum
bilirubin and prothrombin index, respectively, and the hazard of death from PBC. Similarly, a3 and
a4 give us the association between the current values of the biomarkers and the hazard of death from
other causes. The extension to more competing risks follows naturally.
3.4.3 Recurrent events and a terminal event
The extensive frailtypack in R has recently been extended to fit a joint model of a continuous
biomarker, a recurrent event process, and a terminal event (Kro´l et al., 2016, 2017). Here, we illustrate
how to fit such a model with megenreg, combining the models and syntax shown in Sections 3.3 and
the above joint longitudinal-survival examples.
. megenreg (canctime trt EV[logb]@a1 EV[logp]@a2 M5[id] , family(weibull, failure(canc)))
> (stime trt EV[logb]@a4 EV[logp]@a5 M5[id]@alpha , family(gompertz, failure(died)))
> (logb fp(1)@l1 fp(1)#M2[id] M1[id] , family(gaussian) timevar(time))
> (logp fp(1)@l2 fp(1)#M4[id] M3[id] , family(gaussian) timevar(time))
With the addition of a fifth random effect, M5[id], we can account for the correlation between
recurrent events, and then link it to the terminal event process, just as above.
3.4.4 Multistate model
The final joint model extension comprises of a multistate process, linked to longitudinal outcomes.
Once more this is a hypothetical setting, to illustrate the feasibility of fitting such a complex model
simply, within the megenreg command. We illustrate an illness-death Markov multistate process,
whose extension relies on the extension of the survival models to allow for left truncation.
. megenreg
> (canctime trt EV[logb]@a1 EV[logp]@a2 , family(weibull, failure(canc)))
> (stimenocanc trt EV[logb]@a4 EV[logp]@a5 ,
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> family(gompertz, failure(diednocanc) ltrunc(canctime))
> (stimecanc trt EV[logb]@a4 EV[logp]@a5 , family(gompertz, failure(diedcanc)))
> (logb fp(1)@l1 fp(1)#M2[id] M1[id] , family(gaussian) timevar(time))
> (logp fp(1)@l2 fp(1)#M4[id] M3[id] , family(gaussian) timevar(time))
By specifying a survival model for each transition, we can form the full joint model by linking
the longitudinal outcome to survival as before. Each of the transition-specific survival models can be
completely different distributions, providing full flexibility.
The above joint models provide a number of methodological extensions. The extensions to more
outcomes, outcomes of different types (non-continuous), higher levels, alternative ways to linking
outcomes, relative survival, all follow naturally within the framework and implementation.
3.5 A user-defined distribution
A central aim of the development of this extended framework is to provide as much generality as
possible, whilst still being easily implementable within the associated software. The first of two core
aspects of this is the complex linear predictor. We now move to the second, allowing non-standard
distributions to be seamlessly incorporated into the estimation engine. As an example, we consider
the case of a Gaussian distributed outcome. We must define a simple function which returns the
observation level log-likelihood contribution contained in a matrix of real number, which we call
gauss logl(). The function must take one input, which must be of type transmorphic, and we call
it in this case, gml. This is our core object which contains all the information needed about the model
to be estimated, and is what is passed to the subroutines. The user must not attempt to edit this
object.
real matrix gauss logl(gml)
{
y = megenreg util depvar(gml) //dep. var.
linpred = megenreg util xzb(gml) //lin. pred.
sdre = exp(megenreg util xb(gml,1)) //anc. param.
return(lnnormalden(y,linpred,sdre)) //logl
}
Our function uses the subroutines to extract the response variable, the complex linear predictor,
any ancillary parameters (applying an exponential transformation, as the standard deviation is esti-
mated on the log scale), and returns the observation level log likelihood contribution for this outcome,
using the official Mata function lnnormalden(). We can now use the standard megenreg syntax as
follows,
. megenreg (logb time time#M2[id] M1[id], family(user, loglf(gauss logl)) np(1))
We tell megenreg that we are using a user defined family, and tell it the name of the Mata function
using the loglfunction() option. We also tell it that we have one ancillary parameter (the standard
deviation of the Gaussian distribution) to estimate through the np() option. Such an approach
means that the user has complete autonomy over the distributional model specified for any particular
outcome, whilst still being able to utilise the complex linear predictor provided by the framework. User-
defined functions can be used in multiple outcome models, alongside standard distributions available
within the command. The example function above is exactly what is implemented in megenreg with
the family(gaussian) option, illustrating how easy it is to define a new distribution through use of
the utility functions provided.
3.6 A non-linear mixed effects example with multiple complex linear predictors
In all previous examples above, we have only considered settings where we have a single complex linear
predictor, with all other ancillary parameters as scalars. Here, we consider relaxing this restriction,
allowing multiple complex linear predictors, within a single outcome model. A central aim of this
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framework, in the context of the software implementation, is to be able to directly implement non-
standard models, which are not available as a freely available package. We consider the example of
Murawska et al. (2012). They developed a non-linear joint model estimated with a Bayesian approach
(code available from the authors). We show how to directly implement their model as a joint model
estimated using maximum likelihood, using megenreg with just a few lines of code. They assumed a
Gaussian response variable, with multiple non-linear predictors each with fixed effects and a random
intercept. The overall non-linear predictor is defined as,
f(t) = β1i + β2i exp
−β3it
where each linear predictor was constrained to be positive,
β1i = exp(X1β1 + u1i)
β2i = exp(X2β2 + u2i)
β3i = exp(X3β3 + u3i)
and for the survival outcome
λ(t) = λ0(t) exp(α1β1i + α2β2i + α3β3i)
where either a Weibull or piecewise constant hazard function was chosen for λ0(t). In terms of
exposition, it’s easier to begin with the call to megenreg that we use to fit this model. Since we have
multiple linear predictors, we consider each one as an outcome model, choosing the first to represent
the main linear predictor, plus the survival outcome model which we will assume as Weibull, as follows,
. megenreg (resp age female M1[id], family(user, llf(nlme logl))
> np(1) timevar(time))
> (age female M2[id], family(null))
> (age female M3[id], family(null))
> (stime age female EV[1]@alpha1 EV[2]@alpha2 EV[3]@alpha3,
> family(weibull, failure(died)))
> , covariance(unstructured)
In the above syntax, we consider the first model specification as our main one, and hence specify
our response variable, the user-defined Mata function to calculate the observation level log likelihood
contribution, and the number of ancillary parameters. The second and third model specifications are
convenient ways to define additional complex linear predictors. They are flagged as such by defining
the family(null), meaning they do not contribute to the log likelihood, but still allow the complex
linear predictor to be defined and evaluated. We now define our user-written function to explain
further,
real matrix nlme logl(gml, t)
{
y = megenreg util depvar(gml) //dep.var.
linpred1 = exp(megenreg util xzb(gml)) //main lin. pred.
linpred2 = exp(megenreg util xzb mod(gml,2)) //extra lin. preds
linpred3 = exp(megenreg util xzb mod(gml,3))
sdre = exp(megenreg util xb(gml,1)) //anc. param
linpred = linpred1 :+ linpred2:*exp(-linpred3:*t) //nonlin. pred
return(lnnormalden(y,linpred,sdre)) //logl
}
We can use an additional function, gml util xzb2(), to extract a complex linear predictor from a
model different to the current one, where current refers to the model in which the family(user) was
specified. The second option of gml util xzb2() tells it which model linear predictor to extract, in
this case we need the second and third. The overall non-linear predictor is then built and passed to
the log normal density function, along with the ancillary parameter for the standard deviation of the
Gaussian response. This is simply an example of the complete flexibility of the implementation, and
of course these few lines of code can be extended to multiple levels, random effects, etc..
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3.7 A user-defined hazard model
We can extend a general hazard model, such as those developed by Kooperberg et al. (1995) and
Crowther and Lambert (2014) to incorporate the complex linear predictor. Consider a survival model
where we wish to model the baseline log hazard function using polynomials of time,
h(y) = h0(y) exp(η) (20)
where
log h0(y) = β0 + β1y + β2y
2 + β3y
3 (21)
Such a model can be implemented similarly to that shown in Section 3.5. We define a function
which takes two inputs, the first being the core object as before, but the second being a real matrix
t, representing time. We require the second input as time will be integrated out to calculate the
cumulative hazard function required in the log likelihood calculation.
real matrix haz(gml, t)
{
//extract and store the complex linear predictor
linpred = megenreg util xzb(gml)
//extract any anciliary parameters
b = megenreg util xb(gml,1),megenreg util xb(gml,2),megenreg util xb(gml,3)
//return the observation level log likelihood
return(exp(linpred :+ b[1] :* t :+ b[2] :* t:^2 :+ b[3] :* t:^3))
}
Our function must return the observation level hazard function. We can then fit a recurrent event
model, for example, using
. megenreg (stime trt M1[id], family(user, hfunction(haz)) np(3))
Alternatively, if the cumulative hazard has a closed form solution, we can use the cumhazard() option
as well, to pass a function which calculates the cumulative hazard function. If only the cumulative
hazard function is specified, then numerical differentiation is used to calculate the hazard function, to
then maximise the log likelihood.
3.8 Mixed effects for the level 1 variance function
A recent paper by Goldstein et al. (2017) proposed a two-level model with complex level 1 variation,
of the form,
yij =X1ijβ1 +Z1ijb1j + ǫij
ǫij ∼ N(0, σ2e)
log(σ2e) =X2ijβ2 +Z2ijb2j(
b1j
b2j
)
∼ N
[(
0
0
)
,
(
Σb1
Σb1b2 Σb2
)]
(22)
They estimated their proposal with a Bayesian approach utilising Markov Chain Monte Carlo methods.
Here we can subsume this proposed model within the extended framework proposed in this article,
and show how to fit it using megenreg, as follows,
real matrix lev1 logl(gml)
{
y = megenreg util depvar(gml) //response
linpred1 = megenreg util xzb(gml) //lin. pred.
varresid = exp(megenreg util xzb mod(gml,2)) //lev1 lin. pred
return(lnnormalden(y,linpred,sqrt(varresid))) //logl
}
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where,
. megenreg (resp female age age#M2[id] M1[id], family(user, llf(lev1 logl)))
(age female M3[id], family(null))
, covariance(unstructured)
Now we can extend the level 1 variance function model in a number of ways, simply through the
complex linear predictor, for example through extending to higher levels, time-dependent effects and
non-linear covariate effects, as discussed in Goldstein et al. (2017). We can of course also incorporate
a non-linear mixed effects model, such as the example in Section 3.6.
4 Discussion
In this article, we have described an extended framework for the analysis of multivariate multilevel
data, primarily through a complex linear predictor, which provides substantial flexibility to meet a
wide variety of settings. Through the complex linear predictor, we allow seamless development of
novel models, and crucially, a way of making them immediately available to researchers through an
accessible implementation. We have further showed how the complex linear predictor (or predictors),
can be used within a non-linear models, either for a single outcome model, or combined with any
number of outcomes and distributions.
In our illustrative examples in Section 3, we developed a number of extensions to the Royston-
Parmar survival model, namely, an arbitrary number of levels and random effects at each level, the
joint frailty setting for the analysis of recurrent event and a terminal event, and the multilevel relative
survival extension. Any of the standard parametric survival models can be used instead, or even a user-
defined model, such as using splines or fractional polynomials to model the baseline hazard function
and time-dependent effects. More research is needed into each particular case to establish performance
in realistic settings through simulation studies. We further developed a number of novel contributions
to the joint longitudinal-survival literature, including allowing biomarker-biomarker interactions in a
multivariate longitudinal joint model, non-proportional hazards in association parameters, and pro-
viding an overarching framework for generalised multivariate multilevel longitudinal-survival models,
which encompasses anything from a multi-state survival setting, to any number of levels and random
effects, and a wide variety of standard and bespoke association structures to link between outcomes.
As discussed earlier in the article, computation time is often a limiting factor with such complex
models, especially with high dimensional random effects. On one side, this issue is becoming less of
a concern due to the ever increasing power of computers, but conversely, now that we have entered
an era of ‘big data’, the size and availability of datasets is also on the increase, which inevitably
increases the computational demand. A potential solution is to use efficient sampling weights, such
as those utilised in a case-cohort design, meaning we no longer have to analyse the full dataset, with
only a minimal loss in precision. This will be investigated in future work, similar in spirit to that
of Rabe-Hesketh and Skrondal (2006). However, often the main challenge with fitting such complex
models is the dimension of the random effects. Through the use of Monte Carlo integration, the
computational burden can be reduced compared to more commonly used Gauss-Hermite quadrature.
This also allowed us to extend all the models described to incorporate t-distributed random effects,
to provide a more robust model setting, or a sensitivity analysis to the usual normal random effects
assumption. Furthermore, we showed how to use level-specific random effect distributions and nu-
merical integration techniques to provide further methods of sensitivity analyses. A further benefit
of MCI is that it can be parallelised through the use of stream random number generators, enabling
more efficient computations. This will be incorporated into a future version of the software.
The implementation uses finite differences to calculate the score and Hessian, which requires re-
peated calls to the log likelihood evaluator. Current work is incorporating analytic derivatives to pro-
vide substantial speed gains. Further extensions include allowing for multiple membership and cross
clasification, and further development of mixed effect location-scale models (Hedeker and Nordgren,
2013).
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The methodology described in this article has all been implemented as a freely available software
package in Stata. The package is currently being ported to R. Installation instructions and many
further examples can be viewd on the accompanying website: mjcrowther.co.uk/software/megenreg.
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